Operating Income (Loss)
Breakdown
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Biotechnology | $325.0M | $462.0M | $390.0M | $508.0M | $441.0M | $531.0M | $352.0M | $540.0M |
| Total | $1.3B | $1.2B | $958.0M | $1.4B | $1.3B | $760.0M | $1.2B | $1.5B |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Biotechnology | $325.0M | $462.0M | $390.0M | $508.0M | $441.0M | $531.0M | $352.0M | $540.0M |
| Total | $1.3B | $1.2B | $958.0M | $1.4B | $1.3B | $760.0M | $1.2B | $1.5B |
We use cookies for analytics. See our Privacy and Cookie Policy.